These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13677003)

  • 1. [Residual disorders in operant behaviour in recovery from MPTP-induced Parkinson's syndrome in monkeys].
    Latanov AV; Tereshchenko LV; Iudin AG; Shul'govskiĭ VV
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(1-2):155-8. PubMed ID: 13677003
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual lesions of operant behavior in monkeys following recovery from MPTP-induced Parkinson-like syndrome.
    Latanov AV; Tereshchenko LV; Yudin AG; Shul'govskii VV
    Neurosci Behav Physiol; 1998; 28(4):431-4. PubMed ID: 9762718
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of amiridin on the MPTP-induced Parkinson-like syndrome in monkeys].
    Burov IuV; Metkalova SE; Kustov AE; Petrov GV; Shul'govskiĭ VV
    Biull Eksp Biol Med; 1992 Nov; 114(11):495-7, 494. PubMed ID: 1290822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G; Morissette M; Parent M; Di Paolo T
    Eur J Neurosci; 2011 May; 33(10):1823-31. PubMed ID: 21501255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
    Willis GL; Robertson AD
    Pharmacol Biochem Behav; 2005 Jan; 80(1):9-26. PubMed ID: 15652376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Visanji NP; Gomez-Ramirez J; Johnston TH; Pires D; Voon V; Brotchie JM; Fox SH
    Mov Disord; 2006 Nov; 21(11):1879-91. PubMed ID: 16960862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insight phenomenon in the regulation of time of performance of behavior acts in monkey (Macaca mulatta)].
    Pirogov AA; Erofeev AI; Romitsyn AA
    Dokl Akad Nauk; 1997 Jul; 355(2):279-81. PubMed ID: 9333416
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys.
    Emborg ME; Shin P; Roitberg B; Sramek JG; Chu Y; Stebbins GT; Hamilton JS; Suzdak PD; Steiner JP; Kordower JH
    Exp Neurol; 2001 Mar; 168(1):171-82. PubMed ID: 11170732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
    Grégoire L; Samadi P; Graham J; Bédard PJ; Bartoszyk GD; Di Paolo T
    Parkinsonism Relat Disord; 2009 Jul; 15(6):445-52. PubMed ID: 19196540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[Reorganization of the operant food acquisition activities in primates in a time-deficit situation] ].
    Pirogov AA; Erofeev AI; Engovatov VV; Pichugin VIu
    Zh Evol Biokhim Fiziol; 2000; 36(4):315-21. PubMed ID: 11075459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Typological characteristics of conditioned reflex learning in monkeys].
    Sheremet IP; Belkaniia GS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(5):888-96. PubMed ID: 3433932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Teaching monkeys complex behavioral tasks].
    Orlov AA; Mochenkov VP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(5):869-77. PubMed ID: 8249461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.
    Shin KS; Zhao TT; Choi HS; Hwang BY; Lee CK; Lee MK
    Brain Res; 2014 Jun; 1567():57-65. PubMed ID: 24747613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys.
    Escola L; Michelet T; Douillard G; Guehl D; Bioulac B; Burbaud P
    Ann Neurol; 2002 Nov; 52(5):581-7. PubMed ID: 12402255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Changes in Saccadic Eye Movement in Hemiparkinsonian MPTP-Treated Monkeys.
    Tereshchenko LV; Anisimov VN; Shul'govsky VV; Latanov AV
    Perception; 2015; 44(8-9):1054-63. PubMed ID: 26562919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mild hypoxia on delyaed differentiation in the monkey (Macaca mulatta).
    Nicholson AN; Wright CM
    Exp Neurol; 1975 Jun; 47(3):535-43. PubMed ID: 1132463
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chronic l-DOPA treatment on 5-HT(1A) receptors in parkinsonian monkey brain.
    Riahi G; Morissette M; Lévesque D; Rouillard C; Samadi P; Parent M; Di Paolo T
    Neurochem Int; 2012 Dec; 61(7):1160-71. PubMed ID: 22940695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
    Shimazu S; Takahata K; Tamashiro A; Yoneda F; Iida Y; Saji H
    J Neural Transm (Vienna); 2003 Aug; 110(8):871-83. PubMed ID: 12898343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The behavior of tamarin monkeys during the learning and realization of instrumental food habits in a competitive situation].
    Maliukova IV; Uvarova IA
    Zh Evol Biokhim Fiziol; 1990; 26(2):221-9. PubMed ID: 2115708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A learning-based approach to artificial sensory feedback leads to optimal integration.
    Dadarlat MC; O'Doherty JE; Sabes PN
    Nat Neurosci; 2015 Jan; 18(1):138-44. PubMed ID: 25420067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.